Form 4: Guardant Health Executive Reports Stock Transactions
SEC Form 4 Filing
John G. Saia, Chief Legal Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On June 15, 2024, John G. Saia, the Chief Legal Officer of Guardant Health, Inc., reported transactions involving common stock.
- 4,017 shares were acquired through the vesting of restricted stock units at a price of $0.
- 1,434 shares were disposed of to cover tax withholding obligations at a price of $30.21 per share.
- Following these transactions, Saia directly owns 28,417 shares of Guardant Health common stock and 8,156 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral filing reflecting standard executive compensation practices. It doesn't indicate any positive or negative sentiment about the company's performance.
Industry Context
This is a routine Form 4 filing, which is common for executives who receive stock-based compensation. It provides transparency into insider transactions and helps maintain market integrity.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they relate to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 06/09/2023 | Date of restricted stock unit award grant. |
| 06/15/2024 | Date of stock transactions (vesting and tax withholding). |
| 06/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.